Metlife stock kpis
Want to see MET full AI Analyst Report?
Expense Ratio
Metlife reported expense ratio of 21.70% in Q2 2026, up 1.0 percentage points from Q1 2026 and up 1.9 percentage points year over year. The highest value was 21.70% in Q3 2025.
Compares operating expenses to revenue (or to premiums, per insurer reporting) to show overall cost efficiency across the company. A lower expense ratio means more revenue converts to profit; a rising ratio points to cost pressure or heavier investment in growth that could dampen near-term margins.
Expense Ratio has shown significant quarter-to-quarter volatility—deep troughs and sharp spikes—rather than a steady downward trend. Management touts an improved 'direct' expense ratio of 11.9% (Q1 2026) and a 12.1% full‑year target despite PineBridge integration, suggesting operating discipline. However, the chart’s sporadic spikes (notably late‑2022 and Q1‑2026) point to seasonality, integration or corporate one‑offs that could pressure cash returns and ROE if they recur; confirm which expense measure underpins management guidance.
MET Expense Ratio
| Period | Expense Ratio |
|---|---|
| Q2 2026Jun 30, 2026 | 21.70% |
| Q1 2026Mar 31, 2026 | 20.70% |
| Q4 2025Dec 31, 2025 | 15.40% |
| Q3 2025Sep 30, 2025 | 21.70% |
| Q2 2025Jun 30, 2025 | 19.80% |
| Q1 2025Mar 31, 2025 | 18.90% |
| Q4 2024Dec 31, 2024 | 17.80% |
| Q3 2024Sep 30, 2024 | 19.90% |
| Q2 2024Jun 30, 2024 | 17.90% |
| Q1 2024Mar 31, 2024 | 20.50% |
| Q4 2023Dec 31, 2023 | 18.60% |
| Q3 2023Sep 30, 2023 | 18.60% |
| Q2 2023Jun 30, 2023 | 17.70% |
| Q1 2023Mar 31, 2023 | 20.30% |
| Q4 2022Dec 31, 2022 | 21.30% |
| Q3 2022Sep 30, 2022 | 11.60% |
| Q2 2022Jun 30, 2022 | 16.20% |
| Q1 2022Mar 31, 2022 | 17.60% |
| Q4 2021Dec 31, 2021 | 16.10% |
| Q3 2021Sep 30, 2021 | 19.20% |
| Q2 2021Jun 30, 2021 | 19.00% |
| Q1 2021Mar 31, 2021 | 19.00% |

